AR049337A1 - 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina - Google Patents

7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina

Info

Publication number
AR049337A1
AR049337A1 ARP050101934A ARP050101934A AR049337A1 AR 049337 A1 AR049337 A1 AR 049337A1 AR P050101934 A ARP050101934 A AR P050101934A AR P050101934 A ARP050101934 A AR P050101934A AR 049337 A1 AR049337 A1 AR 049337A1
Authority
AR
Argentina
Prior art keywords
group
linear
branched
phe
integer
Prior art date
Application number
ARP050101934A
Other languages
English (en)
Spanish (es)
Inventor
Pozzo Alma Dal
Ming Hong Ni
Sergio Penco
Lucio Merlini
Valle Sabrina Dalla
Giuseppe Giannini
Maria Ornella Tinti
Claudio Pisano
Domenico Alloatti
Loredana Vesci
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Publication of AR049337A1 publication Critical patent/AR049337A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP050101934A 2004-05-13 2005-05-12 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina AR049337A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000242A ITRM20040242A1 (it) 2004-05-13 2004-05-13 "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.

Publications (1)

Publication Number Publication Date
AR049337A1 true AR049337A1 (es) 2006-07-19

Family

ID=35124315

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101934A AR049337A1 (es) 2004-05-13 2005-05-12 7-t-butoxiiminometilcamptotecina conjugada en la posicion 20 con antagonistas de la integrina

Country Status (12)

Country Link
US (1) US7589099B2 (cg-RX-API-DMAC7.html)
EP (1) EP1747020A2 (cg-RX-API-DMAC7.html)
JP (1) JP2007537243A (cg-RX-API-DMAC7.html)
CN (1) CN101065150A (cg-RX-API-DMAC7.html)
AR (1) AR049337A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005243883A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0511077A (cg-RX-API-DMAC7.html)
CA (1) CA2562569A1 (cg-RX-API-DMAC7.html)
IT (1) ITRM20040242A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06012885A (cg-RX-API-DMAC7.html)
TW (1) TW200538123A (cg-RX-API-DMAC7.html)
WO (1) WO2005110486A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
WO2011086553A1 (en) * 2010-01-13 2011-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Cyclic peptides, compositions comprising them and uses thereof as nucleases of nucleotidic macromolecules
CN103275094B (zh) * 2013-05-08 2015-07-08 中国农业科学院植物保护研究所 (20s)-喜树碱的衍生物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815812A1 (de) * 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
DK1044977T3 (da) * 1999-03-09 2002-07-08 Sigma Tau Ind Farmaceuti Camptothecinderivater med antitumoraktivitet
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.

Also Published As

Publication number Publication date
BRPI0511077A (pt) 2007-12-26
TW200538123A (en) 2005-12-01
US20070225311A1 (en) 2007-09-27
WO2005110486A3 (en) 2007-03-08
CA2562569A1 (en) 2005-11-24
EP1747020A2 (en) 2007-01-31
CN101065150A (zh) 2007-10-31
MXPA06012885A (es) 2007-08-14
WO2005110486A2 (en) 2005-11-24
AU2005243883A1 (en) 2005-11-24
JP2007537243A (ja) 2007-12-20
ITRM20040242A1 (it) 2004-08-13
US7589099B2 (en) 2009-09-15

Similar Documents

Publication Publication Date Title
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
AR047928A1 (es) Derivados de tetrahidropiridoindol
ATE457781T1 (de) Orale zusammensetzungen mit extrakten von rosmarin und zugehörige verfahren
CY1113267T1 (el) Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1
ECSP045253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
PT1117440E (pt) Composicoes farmaceuticas que contem paclitaxel
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
BR0015095A (pt) Concentrados não aquosos ou pobres em água de misturas de substâncias-ativas para a proteção de plantas
ES2116447T3 (es) Una composicion farmaceutica que contiene un sistema definido de lipidos.
BRPI0513460A (pt) composição aquosa suave apropriada para a limpeza do cabelo e da pele
BR0116168A (pt) Formulação repelente de inseto liberável por dispositivo piezelétrico
CR8766A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
ECSP066950A (es) Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2
CY1111983T1 (el) Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο
BR0211995A (pt) Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação
KR102560772B9 (ko) 신규한 이온화지질 및 이를 이용한 지질나노입자 조성물
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
AR048949A1 (es) Camptotecina conjugada en posicion 7 con antagonistas de la integrina
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
MX2024009773A (es) Composicion farmaceutica que comprende derivados de difenildiazol y metodos de uso.
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal